Deficient Inhibitory Cortical Networks in Antipsychotic-Naive Subjects at Risk of Developing First-Episode Psychosis and First-Episode Schizophrenia Patients: A Cross-Sectional Study

BACKGROUND Impaired cortical inhibition is a well-established finding in schizophrenia patients and has been linked to dysfunctional gamma-aminobutyric acid (GABA)ergic transmission. However, there have been no previous studies investigating cortical excitability with particular regard to intracortical inhibitory networks in antipsychotic-naive subjects at risk of developing first-episode psychosis. METHODS A total of 18 subjects at risk, 18 first-episode schizophrenia patients, and 18 healthy control subjects were included in this study. Transcranial magnetic stimulation over the left primary motor cortex was used to determine short-latency intracortical inhibition, intracortical facilitation, and the contralateral silent period (CSP). Short-latency intracortical inhibition can be considered as a parameter of GABA type A (GABA(A))-mediated inhibition and it has been proposed that CSP can test GABA type B (GABA(B))-mediated inhibitory intracortical networks. RESULTS Subjects at risk and first-episode patients showed a reduced short-latency intracortical inhibition compared with healthy control subjects, suggesting reduced GABA(A)-mediated inhibition. First-episode patients had a prolonged CSP duration compared with the other two groups, implying a GABA(B) imbalance only in patients with full-blown psychosis. Analyses did not reveal group differences for intracortical facilitation. CONCLUSIONS These results indicate specific alterations in inhibitory cortical networks in subjects at risk and in first-episode patients. It appears that there is already a cortical inhibitory deficit in at-risk individuals. These results suggest a possible GABA(A) dysfunction early in the disease course, whereas alterations in GABA(B) functionality seem to occur later in the disease's progression. Future longitudinal studies will be needed to clarify this inhibitory deficit and its relation to the transition to psychosis.

[1]  R. Paz,et al.  Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. , 2006, The American journal of psychiatry.

[2]  P. Falkai,et al.  Innovative treatment approaches in schizophrenia enhancing neuroplasticity: aerobic exercise, erythropoetin and repetitive transcranial magnetic stimulation. , 2012, Current pharmaceutical biotechnology.

[3]  Karl J. Friston,et al.  Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring , 2009, Schizophrenia bulletin.

[4]  J C Rothwell,et al.  Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. , 1998, Electroencephalography and clinical neurophysiology.

[5]  M. Nitsche,et al.  Impaired long-term depression in schizophrenia: A cathodal tDCS pilot study , 2012, Brain Stimulation.

[6]  J. Meador-Woodruff,et al.  Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities , 2004, Schizophrenia Research.

[7]  S. Kapur,et al.  Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. , 2002, Archives of general psychiatry.

[8]  B. Langguth,et al.  Cortical excitability in neuroleptic-naive first-episode schizophrenic patients , 2004, Schizophrenia Research.

[9]  Robert Chen,et al.  Increased cortical inhibition in persons with schizophrenia treated with clozapine , 2008, Journal of psychopharmacology.

[10]  Paolo Fusar-Poli,et al.  Gray matters! — Mapping the transition to psychosis , 2011, Schizophrenia Research.

[11]  F. Benes.  Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders , 2011, Neuropharmacology.

[12]  P. Fitzgerald,et al.  A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation , 2002, Schizophrenia Research.

[13]  Benjamin W. H. Lim,et al.  Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars , 2007, Proceedings of the National Academy of Sciences.

[14]  P. Gourzis,et al.  Cortical motor neurophysiology of patients with schizophrenia: A study using transcranial magnetic stimulation , 2010, Psychiatry Research.

[15]  P. Fitzgerald,et al.  The Relationship Between Cortical Inhibition, Antipsychotic Treatment, and the Symptoms of Schizophrenia , 2009, Biological Psychiatry.

[16]  M. C. Saka,et al.  Cortical inhibition in first-degree relatives of schizophrenic patients assessed with transcranial magnetic stimulation. , 2005, The international journal of neuropsychopharmacology.

[17]  L. Niehaus,et al.  Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia. , 2004, Pharmacopsychiatry.

[18]  J. Lieberman,et al.  Auditory P300 in high-risk, recent-onset and chronic schizophrenia , 2005, Schizophrenia Research.

[19]  P. Fitzgerald,et al.  A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia , 2002, Psychopharmacology.

[20]  J. Rothwell,et al.  The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse , 2004, Clinical Neurophysiology.

[21]  Tyrone D. Cannon,et al.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. , 2008, Archives of general psychiatry.

[22]  J. Brinkmeyer,et al.  Auditory P300 in individuals clinically at risk for psychosis. , 2008, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[23]  B Conrad,et al.  Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia , 1998, Muscle & nerve.

[24]  Georg Juckel,et al.  Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia , 2008, Schizophrenia Research.

[25]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[26]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[27]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[28]  Philip K. McGuire,et al.  Regional Gray Matter Volume Abnormalities in the At Risk Mental State , 2007, Biological Psychiatry.

[29]  P H Ellaway,et al.  An Investigation of Motor Function in Schizophrenia using Transcranial Magnetic Stimulation of the Motor Cortex , 1996, British Journal of Psychiatry.

[30]  Ullrich K. H. Ecker,et al.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse , 2009, Psychopharmacology.

[31]  A. Aleman,et al.  Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. , 2010, The Journal of clinical psychiatry.

[32]  W. Paulus,et al.  Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex , 2006, Clinical Neurophysiology.

[33]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[34]  P. Mcguire,et al.  Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis , 2010, Neuroscience & Biobehavioral Reviews.

[35]  P. Falkai,et al.  Schizophrenia as a disorder of disconnectivity , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[36]  Paolo Fusar-Poli,et al.  Mapping Prodromal Psychosis , 2011 .

[37]  T. Schneider-Axmann,et al.  Motor Circuit Abnormalities in First-episode Schizophrenia Assessed with Transcranial Magnetic Stimulation , 2009, Pharmacopsychiatry.

[38]  Ullrich K. H. Ecker,et al.  Reduced cortical inhibition in first-episode schizophrenia , 2008, Schizophrenia Research.

[39]  F. Benes.  Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. , 1998, Schizophrenia bulletin.

[40]  A. Sampson,et al.  GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. , 2001, The American journal of psychiatry.

[41]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[42]  Ulf Ziemann,et al.  TMS and drugs , 2004, Clinical Neurophysiology.

[43]  M. Nitsche,et al.  Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation , 2011, Behavioural Brain Research.

[44]  André Aleman,et al.  Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. , 2007, The Journal of clinical psychiatry.

[45]  P. McGuire,et al.  Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. , 2010, Archives of general psychiatry.

[46]  F. Schneider,et al.  Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. , 2011, Schizophrenia bulletin.

[47]  E. Bramon,et al.  Neural correlates of movement generation in the ‘at‐risk mental state’ , 2010, Acta psychiatrica Scandinavica.

[48]  G. Juckel,et al.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. , 2010, Archives of general psychiatry.

[49]  B. Langguth,et al.  Modulation of human motor cortex excitability by quetiapine , 2008, Psychopharmacology.

[50]  P. Fitzgerald,et al.  A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia , 2002, Psychiatry Research: Neuroimaging.

[51]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[52]  Paul B. Fitzgerald,et al.  Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia , 2004, Biological Psychiatry.

[53]  S. Kapur,et al.  Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation , 2003, Psychopharmacology.

[54]  B. Christensen,et al.  Dysfunctional neural plasticity in patients with schizophrenia. , 2008, Archives of general psychiatry.

[55]  Paolo Fusar-Poli,et al.  Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis , 2007, Neuroscience & Biobehavioral Reviews.

[56]  T. McGlashan,et al.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.

[57]  O. Snead,et al.  Evidence that clozapine directly interacts on the GABAB receptor , 2011, Neuroreport.

[58]  S. Kapur,et al.  The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.

[59]  T. Hashimoto,et al.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. , 2011, Cerebral cortex.

[60]  E. Walker.  Developmentally moderated expressions of the neuropathology underlying schizophrenia. , 1994, Schizophrenia bulletin.

[61]  Michael Wagner,et al.  Prediction of Psychosis by Mismatch Negativity , 2011, Biological Psychiatry.

[62]  Federico Ranieri,et al.  GABAA receptor subtype specific enhancement of inhibition in human motor cortex , 2006, The Journal of physiology.

[63]  C. Marsden,et al.  Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.

[64]  Robert Chen,et al.  Interactions between inhibitory and excitatory circuits in the human motor cortex , 2003, Experimental Brain Research.

[65]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[66]  David A Lewis,et al.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. , 2008, The American journal of psychiatry.

[67]  A. Mechelli,et al.  Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. , 2011, Archives of general psychiatry.

[68]  I. Tendolkar,et al.  Sensory Gating in Schizophrenia: P50 and N100 Gating in Antipsychotic-Free Subjects at Risk, First-Episode, and Chronic Patients , 2008, Biological Psychiatry.

[69]  A. Mechelli,et al.  Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. , 2011, Archives of general psychiatry.

[70]  P. Mcguire,et al.  Mapping prodromal psychosis: A critical review of neuroimaging studies , 2012, European Psychiatry.

[71]  P. Fitzgerald,et al.  Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. , 2008, Cerebral cortex.

[72]  P. McGuire,et al.  Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis , 2011, Molecular Psychiatry.

[73]  Matthew J. Kempton,et al.  Neuroanatomy of vulnerability to psychosis: A voxel-based meta-analysis , 2011, Neuroscience & Biobehavioral Reviews.